Infant Formula Made in America Act of 2024
Latest Action
Referred to the House Committee on Ways and Means.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Infant Formula Made in America Act of 2024 is a House bill introduced in the 118th Congress that relates to the policy area of taxation. The bill was referred to the House Committee on Ways and Means on March 20, 2024, but no official summary or full text is publicly available. The bill is currently classified as failed or expired, indicating it did not advance to become law during the 118th Congress.
This bill aimed to address issues related to infant formula production in the United States through tax-related measures but did not progress beyond committee referral and ultimately expired.
- The bill is titled 'Infant Formula Made in America Act of 2024' and was introduced in the House of Representatives.
- It falls under the policy area of taxation, suggesting it may involve tax incentives or regulations related to infant formula manufacturing.
- The latest recorded action was referral to the House Committee on Ways and Means on March 20, 2024, with no further legislative movement.
['Domestic infant formula manufacturers', 'Tax authorities and policymakers involved in taxation', 'Potentially consumers of infant formula if the bill intended to influence domestic production']
['Lack of publicly available full bill text and official summary limits understanding of specific provisions and implementation details.', 'Unclear funding mechanisms or tax policy changes could pose challenges for enforcement and oversight.', "The bill's failure to advance raises questions about legislative support and feasibility."]
The bill was introduced during the 118th Congress and referred to the House Committee on Ways and Means, which handles taxation and revenue-related legislation. Its failure to progress suggests limited legislative momentum or competing priorities within the committee or chamber. The focus on infant formula production aligns with ongoing policy discussions about domestic manufacturing and supply chain resilience.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential stimulation of domestic infant formula manufacturing through tax incentives or regulations if provisions were enacted.', 'Possible impact on infant formula prices and availability depending on the nature of tax policy changes.', 'Influence on supply chain resilience for infant nutrition products in the U.S.']
The absence of a full bill text and official summary significantly limits transparency and public understanding of the bill's provisions and potential impacts. This lack of documentation also restricts effective oversight and informed debate. The bill's referral to the House Committee on Ways and Means aligns with its taxation focus, but no further legislative actions were recorded, indicating stalled progress.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.